Medicine · Ischemic Heart Disease (Presentation, ECG, Complications, Management)

Which landmark trial demonstrated that routine early invasive strategy (within 24 hours) was superior to selective invasive strategy in high-risk NSTEMI patients, leading to current NSTEMI guidelines recommending early angiography?

  • A COURAGE trial
  • B TIMACS trial
  • C ISCHEMIA trial
  • D GUSTO trial
Correct answer: B. TIMACS trial

Explanation

The TIMACS (Timing of Intervention in Patients with Acute Coronary Syndromes) trial showed that early invasive strategy (within 24 hours) reduced the composite endpoint of death, MI, and stroke at 6 months compared to delayed strategy in high-risk NSTEMI patients (GRACE score >140). COURAGE showed PCI vs. medical therapy in stable angina. ISCHEMIA addressed stable ischaemic heart disease. GUSTO evaluated thrombolytics in STEMI.

Reference: Harrison's Principles of Internal Medicine, 21st ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Ischemic Heart Disease (Presentation, ECG, Complications, Management) MCQs

See all Ischemic Heart Disease (Presentation, ECG, Complications, Management) MCQs →